Records containing: Ulcerative Colitis

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2025-11-19
  Clinical Study to Evaluate Safety and Efficacy of Rupatadine in Patients With Ulcerative Colitis.
• CLINICAL_TRIALS study record update · 2025-11-12
  Digital Support for Mental Health Intervention in Patients With Inflammatory Bowel Disease
• CLINICAL_TRIALS study record update · 2025-11-10
  Testing of an Educational Tool for Patients With Melanoma and Concomitant Autoimmune Disease Who Are Candidates for Adjuvant Therapy With Immune Checkpoint Inhibitors: Acceptability and Usability With Patients and Providers
• CLINICAL_TRIALS study record update · 2025-11-04
  Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease Management (PROMOTE IBD)
• CLINICAL_TRIALS study record update · 2025-10-24
  A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Study to Evaluate the Efficacy and Safety of ABX464 Once Daily for Induction Treatment in Subjects With Moderately to Severely Active Ulcerative Colitis
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2025-10-24
  A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Study to Evaluate the Efficacy and Safety of ABX464 Once Daily for Induction Treatment in Subjects With Moderately to Severely Active Ulcerative Colitis
• CLINICAL_TRIALS study record update · 2025-10-24
  A Randomized, Double-blind, Multicenter Phase III Study to Evaluate the Long-term Efficacy and Safety of ABX464 25 mg or 50 mg Once Daily as a Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
• CLINICAL_TRIALS study record update · 2025-10-20
  Study of Novel Therapeutics for Acute Remedy of Colitis
• CLINICAL_TRIALS study record update · 2025-10-20
  Mirikizumab Therapy is Effective for Patients With Moderate to Severe Ulcerative Colitis Patients Whose Geboes Score Grade is ≥3.2) on Endoscopic Biopsy
• CLINICAL_TRIALS study record update · 2025-10-16
  A Multi-Center, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate Long-Term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Ulcerative Colitis Who Completed the Study M11-290
• CLINICAL_TRIALS study record update · 2025-10-15
  A Phase 2 Long-Term Extension (LTE) Study to Evaluate The Safety and Efficacy of Efavaleukin Alfa in Subjects With Moderately to Severely Active Ulcerative Colitis
• CLINICAL_TRIALS study record update · 2025-10-07
  A Multicenter, Randomized Study to Evaluate the Safety and Efficacy of Lutikizumab for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
• CLINICAL_TRIALS study record update · 2025-10-06
  Post-Marketing Surveillance (Usage Results Study) of Vedolizumab Subcutaneous Injection in Patients With Ulcerative Colitis or Crohn's Disease in South Korea
• CLINICAL_TRIALS study record update · 2025-10-03
  A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis
• CLINICAL_TRIALS study record update · 2025-09-30
  Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF Agents in the Management of Patients With Inflammatory Bowel Disease Treated With Anti-TNFalpha Biotherapy.
• CLINICAL_TRIALS study record update · 2025-09-30
  A Double-blind Placebo-controlled Phase 1 Study to Evaluate the Safety and Efficacy of MB-001 in Single and Multiple Ascending Doses in Healthy Human Participants
• CLINICAL_TRIALS study record update · 2025-09-30
  A Multicenter, Phase 3b, Open-Label, Single-Arm Study to Investigate Bowel Urgency and Its Relationship With Other Outcome Measures in Adults With Moderately to Severely Active Ulcerative Colitis Treated With Mirikizumab
• CLINICAL_TRIALS study record update · 2025-09-30
  A Multicenter, Phase 3b, Open-Label, Single-Arm Study to Investigate Bowel Urgency and Its Relationship With Other Outcome Measures in Adults With Moderately to Severely Active Ulcerative Colitis Treated With Mirikizumab
• CLINICAL_TRIALS study record update · 2025-09-24
  Evaluation of a Remote Monitoring Application in the Follow-up of Patients With Active Inflammatory Bowel Diseases: The SECURITY Trial
• CLINICAL_TRIALS study record update · 2025-09-19
  An Open-Label, Phase 3 Study to Evaluate the Pharmacokinetics, Safety, and Immunogenicity of Vedolizumab Subcutaneous in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
• CLINICAL_TRIALS study record update · 2025-09-18
  A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam BID for 2 Weeks, Followed by QD for 4 Weeks, in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis
• CLINICAL_TRIALS study record update · 2025-09-18
  Evaluation of Microbiota and Probiotic Therapy in Ulcerative Colitis Patients
• CLINICAL_TRIALS study record update · 2025-09-16
  CP101 for the Treatment of Ulcerative Colitis
• CLINICAL_TRIALS study record update · 2025-09-16
  A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets n Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
• CLINICAL_TRIALS study record update · 2025-09-12
  Long-term Efficacy and Safety of Fecal Microbiota Transplantation in Patients With Ulcerative Colitis